7-((6-(4-fluorophenyl)pyridin-3-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine

ID: ALA1078268

PubChem CID: 46882753

Max Phase: Preclinical

Molecular Formula: C22H21FN2O2S

Molecular Weight: 396.49

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Cc1ccc2c(c1)CCNCC2)c1ccc(-c2ccc(F)cc2)nc1

Standard InChI:  InChI=1S/C22H21FN2O2S/c23-20-5-3-18(4-6-20)22-8-7-21(14-25-22)28(26,27)15-16-1-2-17-9-11-24-12-10-19(17)13-16/h1-8,13-14,24H,9-12,15H2

Standard InChI Key:  MSCYJFQRYSADGM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    6.2700   -4.8171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2687   -5.6411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9870   -6.0544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9851   -4.4039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4982   -5.2332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1426   -4.4862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3398   -4.3028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1404   -5.9733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3366   -6.1563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6958   -5.6387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6948   -4.8130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5534   -6.0540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8381   -5.6410    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.1229   -6.0539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4178   -4.9227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2438   -4.9227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4094   -5.6401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6947   -6.0523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6942   -6.8790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4144   -7.2920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1262   -6.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9814   -7.2945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2652   -6.8807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5510   -7.2939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5516   -8.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2724   -8.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9837   -8.1170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1626   -8.5354    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
  2 12  1  0
  6  7  1  0
 12 13  1  0
  5  8  1  0
 13 14  1  0
  9 10  1  0
 13 15  2  0
 10 11  1  0
 13 16  2  0
 11  7  1  0
 14 17  2  0
  8  9  1  0
 17 18  1  0
  2  3  1  0
 18 19  2  0
 19 20  1  0
  3 10  2  0
 20 21  2  0
 21 14  1  0
 22 23  2  0
  1  2  2  0
 23 24  1  0
 11  4  2  0
 24 25  2  0
  4  1  1  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 19 22  1  0
 25 28  1  0
M  END

Associated Targets(Human)

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Stomach (183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.49Molecular Weight (Monoisotopic): 396.1308AlogP: 3.55#Rotatable Bonds: 4
Polar Surface Area: 59.06Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.86CX LogP: 3.54CX LogD: 1.14
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.73Np Likeness Score: -1.32

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source